PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of yjbmLink to Publisher's site
 
Yale J Biol Med. 1992 Sep-Oct; 65(5): 457–469.
PMCID: PMC2589746

Recent results in animal models of pancreatic carcinoma: histogenesis of tumors.

Abstract

Animal models of carcinoma of the pancreas provide new information regarding the pathways for histogenesis of the tumors. Four models, induced by chemical carcinogens or transgenic methods, are reviewed briefly from this perspective. Recent reports indicate that carcinomas with a ductal phenotype can arise from transformed acinar cells in rodents. A transgenic mouse model provides evidence that anaplastic carcinomas and islet cell tumors may arise from primitive cells that express the elastase gene, yet retain the potential to differentiate as islet cells. In a nitrosamine-induced hamster model, ductal carcinomas appear to arise directly from ductal cells. Carcinomas in this model contained mutations in the c-K-ras oncogene that are similar to those reported in about 75 percent of human pancreatic carcinomas, whereas acinar cell carcinomas of rats lacked this mutation. The histologic type of a carcinoma may reflect the cell of origin, but this statement is not always true. Therefore, classification of tumors on the basis of phenotype rather than on the presumed cell of origin is recommended. Among the animal models, the carcinomas in hamster pancreas rank as most similar to human pancreatic ductal adenocarcinomas in regard to the phenotype of the tumors and the prevalence of the c-K-ras mutation.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Boring CC, Squires TS, Tong T. Cancer statistics, 1992. CA Cancer J Clin. 1992 Jan-Feb;42(1):19–38. [PubMed]
  • Bell RH, Jr, Kuhlmann ET, Jensen RT, Longnecker DS. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas. Cancer Res. 1992 Jun 15;52(12):3295–3299. [PubMed]
  • Ornitz DM, Hammer RE, Messing A, Palmiter RD, Brinster RL. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science. 1987 Oct 9;238(4824):188–193. [PubMed]
  • Sandgren EP, Quaife CJ, Paulovich AG, Palmiter RD, Brinster RL. Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):93–97. [PubMed]
  • Longnecker DS, Kuhlmann ET, Freeman DH., Jr Characterization of the elastase 1-simian virus 40 T-antigen mouse model of pancreatic carcinoma: effects of sex and diet. Cancer Res. 1990 Dec 1;50(23):7552–7554. [PubMed]
  • Glasner S, Memoli V, Longnecker DS. Characterization of the ELSV transgenic mouse model of pancreatic carcinoma. Histologic type of large and small tumors. Am J Pathol. 1992 May;140(5):1237–1245. [PubMed]
  • Bell RH, Jr, Memoli VA, Longnecker DS. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene. Carcinogenesis. 1990 Aug;11(8):1393–1398. [PubMed]
  • Pour PM, Egami H, Takiyama Y. Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications. Gastroenterology. 1991 Feb;100(2):529–536. [PubMed]
  • Shibata D, Capella G, Perucho M. Mutational activation of the c-K-ras gene in human pancreatic carcinoma. Baillieres Clin Gastroenterol. 1990 Mar;4(1):151–169. [PubMed]
  • Cerny WL, Mangold KA, Scarpelli DG. Activation of K-ras in transplantable pancreatic ductal adenocarcinomas of Syrian golden hamsters. Carcinogenesis. 1990 Nov;11(11):2075–2079. [PubMed]
  • Fujii H, Egami H, Chaney W, Pour P, Pelling J. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol Carcinog. 1990;3(5):296–301. [PubMed]
  • van Kranen HJ, Vermeulen E, Schoren L, Bax J, Woutersen RA, van Iersel P, van Kreijl CF, Scherer E. Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. Carcinogenesis. 1991 Aug;12(8):1477–1482. [PubMed]
  • Schaeffer BK, Zurlo J, Longnecker DS. Activation of c-Ki-ras not detectable in adenomas or adenocarcinomas arising in rat pancreas. Mol Carcinog. 1990;3(3):165–170. [PubMed]
  • Hall PA, Lemoine NR, Murphy G, Dowling RH. Molecular differences between human and experimental pancreaticobiliary diversion-induced rat pancreatic neoplasia. Gut. 1991 May;32(5):533–535. [PMC free article] [PubMed]
  • Longnecker D. Experimental pancreatic cancer: role of species, sex and diet. Bull Cancer. 1990;77(1):27–37. [PubMed]
  • Longnecker DS. Hormones and pancreatic cancer. Int J Pancreatol. 1991 Summer;9:81–86. [PubMed]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine